ESC Premium Access

Actual management costs of patients with non-valvular atrial fibrillation treated with percutaneous left atrial appendage closure or oral anticoagulation

Congress Presentation

About the speaker

Doctor Giuseppe d'ancona

Vivantes Klinikum Am Urban, Berlin (Germany)
0 follower

160 more presentations in this session

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Speaker: Associate Professor T. Mine (Hyogo, JP)

Thumbnail

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Speaker: Doctor M. Sugitani (Nishinomiya, JP)

Thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)

Thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Montreal, CA)

Thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)

Thumbnail

Access the full session

Atrial fibrillation e-posters

Speakers: Doctor G. d'ancona, Associate Professor T. Mine, Doctor M. Sugitani, Mr T. Klamer, Doctor M. Mansour...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Time to act: Stabilising the vulnerable plaque with PCSK9i.

30 August 2021

Open Access

Introduction.

30 August 2021

Open Access

Management of ASCVD risk in apparently healthy people.

30 August 2021

ESC 365 is supported by

logo Novo Nordisk